Search results for: 'research area apoptosis bcl 2 family'
-
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR inhibitor
-
A2251 Tivozanib (AV-951)Target: VEGFRSummary: VEGFR inhibitor,potent and selective
-
A8255 Sunitinib malate2 CitationTarget: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
-
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
-
A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor
-
A1882 Cediranib (AZD217)Target: VEGFRSummary: VEGFR inhibitor receptor,highly potent
-
A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor
-
A8550 Telatinib (BAY 57-9352)Target: VEGFR|PDGFR|c-KitSummary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
-
B5864 Fruquintinib(HMPL-013)Target: VEGFRSummary: Potent and selective inhibitor of VEGFR 1, 2, 3